Acorah Software Products - Accounts Production 19.3.600 false true 28 February 2025 1 March 2024 false 1 March 2025 28 February 2026 28 February 2026 10691560 S Hospital true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10691560 2025-02-28 10691560 2026-02-28 10691560 2025-03-01 2026-02-28 10691560 frs-core:CurrentFinancialInstruments 2026-02-28 10691560 frs-core:CapitalRedemptionReserve 2026-02-28 10691560 frs-core:ShareCapital 2026-02-28 10691560 frs-core:RetainedEarningsAccumulatedLosses 2026-02-28 10691560 frs-bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 10691560 frs-bus:FilletedAccounts 2025-03-01 2026-02-28 10691560 frs-bus:SmallEntities 2025-03-01 2026-02-28 10691560 frs-bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 10691560 frs-bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 10691560 frs-bus:OrdinaryShareClass1 2025-03-01 2026-02-28 10691560 frs-bus:OrdinaryShareClass1 2026-02-28 10691560 frs-bus:OrdinaryShareClass2 2025-03-01 2026-02-28 10691560 frs-bus:OrdinaryShareClass2 2026-02-28 10691560 1 2025-03-01 2026-02-28 10691560 frs-core:ListedExchangeTraded 2026-02-28 10691560 frs-core:ListedExchangeTraded 2025-02-28 10691560 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-02-28 10691560 frs-core:CostValuation frs-core:ListedExchangeTraded 2026-02-28 10691560 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-02-28 10691560 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2026-02-28 10691560 frs-bus:Director1 2025-03-01 2026-02-28 10691560 frs-countries:EnglandWales 2025-03-01 2026-02-28 10691560 2024-02-29 10691560 2025-02-28 10691560 2024-03-01 2025-02-28 10691560 frs-core:CurrentFinancialInstruments 2025-02-28 10691560 frs-core:CapitalRedemptionReserve 2025-02-28 10691560 frs-core:ShareCapital 2025-02-28 10691560 frs-core:RetainedEarningsAccumulatedLosses 2025-02-28 10691560 frs-bus:OrdinaryShareClass1 2024-03-01 2025-02-28 10691560 frs-bus:OrdinaryShareClass2 2024-03-01 2025-02-28
Registered number: 10691560
Oneragtime Keli 2 Limited
Unaudited Financial Statements
For The Year Ended 28 February 2026
Contents
Page
Statement of Financial Position 1—2
Notes to the Financial Statements 3—4
Page 1
Statement of Financial Position
Registered number: 10691560
2026 2025
Notes $ $ $ $
FIXED ASSETS
Investments 4 1,010,250 1,010,250
1,010,250 1,010,250
CURRENT ASSETS
Debtors 5 16,869 15,275
16,869 15,275
Creditors: Amounts Falling Due Within One Year 6 (45,270 ) (43,676 )
NET CURRENT ASSETS (LIABILITIES) (28,401 ) (28,401 )
TOTAL ASSETS LESS CURRENT LIABILITIES 981,849 981,849
NET ASSETS 981,849 981,849
CAPITAL AND RESERVES
Called up share capital 7 4,451 4,451
Capital redemption reserve 261 261
Income Statement 977,137 977,137
SHAREHOLDERS' FUNDS 981,849 981,849
Page 1
Page 2
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
S Hospital
Director
15/09/2026
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Oneragtime Keli 2 Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10691560 . The registered office is Unit D, Heathmans House, 19 Heathmans Road, London, SW6 4TJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
2.2. Turnover
Turnover is recognised as management fees equal to the professional fees incurred during the year under review.
2.3. Foreign Currencies
The functional currency is United States dollars (USD) and as such the accounts have been prepared in USD.
2.4. Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in
equity. 
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
2.5. Investments
Where possible, equity investments are valued in accordance with IPEVC (International Private Equity &
Venture Capital) valuation guidelines, otherwise they are valued at cost less impairments.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
4. Investments
Listed
$
Cost or Valuation
As at 1 March 2025 1,010,250
As at 28 February 2026 1,010,250
Provision
As at 1 March 2025 -
As at 28 February 2026 -
Net Book Value
As at 28 February 2026 1,010,250
As at 1 March 2025 1,010,250
Where possible, equity investments are valued in accordance with IPEVC (International Private Equity & Venture Capital) valuation guidelines, otherwise they are valued at cost less impairments.
As the investments are not listed, the valuation is based on the last issued share price and where investments are revalued upwards, the value does not reflect any performance fee due.
Page 3
Page 4
5. Debtors
2026 2025
$ $
Due within one year
Other debtors 16,869 15,275
6. Creditors: Amounts Falling Due Within One Year
2026 2025
$ $
Trade creditors 25,495 25,495
Other creditors 19,775 18,181
45,270 43,676
7. Share Capital
2026 2025
Allotted, called up and fully paid $ $
24,513 Ordinary Shares of $ 0.10 each 2,451 2,451
2,000 Ordinary A shares of $ 1.00 each 2,000 2,000
4,451 4,451
8. Ultimate Controlling Party
The immediate and ultimate parent undertaking of the company is OneRagtime Venture Cloud a company incorporated in France with registered number SIREN 831125364 and trading address 60 Rue de Londres, Paris, 75008, France.
The ultimate controlling party is Mrs S C Hospital.
Page 4